NEWARK, DE | The Algorithmic Clinical Audit Trail Market was valued at USD 1.2 billion in 2025 and is projected to reach USD 1.5 billion in 2026, expanding at a CAGR of 12.14% through 2036. Sustained regulatory pressure and the need for immutable provenance in AI-driven clinical systems are expected to drive the market to USD 4.7 billion by 2036. This growth reflects a structural...

NEWARK, DE —The global antibiotics active pharmaceutical ingredient (API) market is projected to reach USD 9,100 million in 2026 and expand to USD 12,000 million by 2036, registering a steady CAGR of 2.8% over the forecast period. This sustained expansion reflects the ongoing need for reliable antibiotic production amid rising bacterial infection prevalence, growing demand for...

Rapid expansion of artificial intelligence in healthcare is creating a critical need for governance platforms that ensure algorithm transparency, regulatory compliance, and patient safety. NEWARK, DE |— The global Clinical AI Model Governance Market is entering a phase of exponential growth as healthcare systems worldwide move to ensure responsible deployment of artificial...

NEWARK, DE | The Clinical Documentation Integrity Automation Market is projected to grow from USD 2.1 billion in 2025 to USD 2.4 billion in 2026, advancing at a CAGR of 14.50% through 2036. Sustained investment and the shift toward value-based care models are expected to propel the market to USD 9.3 billion by 2036. The transformation reflects a structural push by healthcare...

The global coronary stents market is set for steady expansion, rising from USD 37.5 billion in 2026 to USD 64.6 billion by 2036, reflecting a compound annual growth rate (CAGR) of 5.6%. Future Market Insights highlights that this trajectory is driven by the enduring worldwide prevalence of coronary artery disease and ongoing improvements in percutaneous coronary intervention (PCI)...

NEWARK, DE | The gynecological examination chairs market was valued at USD 697.7 million in 2025 and is estimated to reach USD 745.8 million in 2026. Future Market Insights projects the market will expand to USD 1.45 billion by 2036, reflecting a steady CAGR of 6.9% over the forecast period. This growth underscores the ongoing shift toward electric positioning systems that enhance...

NEWARK, DE | The HIV self-testing market stood at USD 240.1 million in 2025. According to Future Market Insights analysis, the market is estimated to expand to USD 272.8 million in 2026 and reach USD 971.8 million by 2036, reflecting a steady CAGR of 13.6% over the forecast period. This absolute dollar growth of USD 699.0 million underscores a major step forward in public...

NEWARK, DE | The global hyaluronic acid products market is estimated to be worth USD 9.43 billion in 2025 and is anticipated to reach USD 15.94 billion by 2035, expanding at a steady CAGR of 5.4% over the forecast period. This growth reflects rising adoption across cosmetic and medical applications, driven by the molecule's natural ability to trap...

NEWARK, DE | The nasal mucosa therapeutics market surpassed USD 5.0 billion in 2025 and is projected to reach USD 5.9 billion in 2026, expanding at a CAGR of 18.3% through 2036. By the end of the forecast period, the market is expected to achieve a valuation of USD 31.7 billion, driven by advanced formulations that bypass hepatic first-pass metabolism and enable rapid systemic...

According to a new report by UnivDatos, the PARP Inhibitors Market is projected to reach USD 13,835 million by 2032, expanding at a robust CAGR of 12.9% during the forecast period. PARP (Poly ADP-ribose Polymerase) inhibitors are a class of targeted cancer therapies that block the activity of PARP enzymes responsible for repairing single-strand DNA breaks. By inhibiting these enzymes, PARP...